Consequences of Failing to Submit a Complete Information Disclosure Statement : Legal Risks, Patent Validity, and Post-Filing Remedies

Introduction : The patent system is designed to reward innovation by granting inventors exclusive rights over their inventions for a limited period. This way, inventors are meant to reveal all their inventions completely so that technological information is publicly known in the long run. This combination of exclusive rights and full disclosure constitutes the basic principle of patent law. To maintain the integrity of the patent system, patent applicants and those who prosecute patents should act in good faith during the examination process.

This duty of disclosure includes the filing of an Information Disclosure Statement (IDS) before the US Patent and Trademark Office (USPTO). The purpose of the IDS is to allow the patent applicant to provide important prior art to the patent examiner. A patent examiner can't be aware of all publications or patents that could be relevant to his or her examination. The duty of disclosure becomes very significant in this respect.

Though the IDS may seem like a mere procedural formality, it means much more than that. An incomplete or inaccurate IDS can result in accusations against the applicant of unfair practices, patent invalidity claims, lengthy proceedings and considerable monetary loss. Though the legal system acknowledges the possibility of honest mistakes on the part of applicants, it still demands that applicants behave in a straightforward, diligent, and good-faith manner.

In this blog post, you will see the importance of the Information Disclosure Statement from the perspective of law, as well as the ramifications that arise when there is no disclosure promptly, along with the ways through which the problems can be remedied.

Understanding the Information Disclosure Statement

Information Disclosure Statement refers to a filing that is made in connection with the examination process for the purpose of disclosing information that is believed to be relevant to the patentability of the inventions. The said information typically includes prior art such as patents, patent applications, scientific and technical journals, conferences, product literature or any other publicly accessible information that would affect the examination process.

The legal underpinning for such an obligation comes in the form of 37 C.F.R, § 1.56, where there is a requirement placed on persons involved in the process of preparing and prosecuting a patent application that they maintain a high standard of honesty and good faith. Such an obligation applies not only to inventors but also to patent attorneys, patent agents and other persons substantially involved in the prosecution of the application. It is important to note that the material information is not every document about the invention. It pertains to the information that may affect the examination of the application in relation to the patentability of the invention. This would mean that the purpose of the requirement is to provide the examiner with information that might affect his judgement.

The procedural rules relating to the submission of an IDS guide timelines, certification, fees that apply in certain instances, and the necessary content to be included. In essence, such regulations serve as a framework designed to enhance both clarity and efficiency.

Why a Complete Information Disclosure Statement Matters

The quality of a patent often depends upon the quality of the examination that precedes its grant. An examiner cannot decide on the patentability of an invention without the information at hand during prosecution; thus, an IDS helps the examiner make an informed decision.

Correct disclosure will also benefit applicants. Patents that were issued with an evaluation of all the pertinent prior art are unlikely to be challenged for their validity in subsequent legal proceedings. It can be stated that investors and business partners show more faith in patents which have a transparent history of prosecution.

In terms of policy, full disclosure builds public trust in the patent system. The exclusive rights given by a patent can have an impact on competition, technological innovation and consumer access to technology. It is for this reason that such exclusive rights should only be issued following a proper evaluation process. Any failure to make such disclosure will undermine this aim because there will be a greater likelihood that a patent will issue on an invention that does not meet statutory requirements.

Therefore, the IDS cannot simply be considered as an administrative form. It is a critical protection that guarantees the sanctity of the entire patent system while minimising any legal or business risks in the future.

Legal Consequences of an Incomplete Information Disclosure Statement

Inequitable Conduct

One of the biggest legal dangers of having an unfinished IDS may come from claims of inequitable conduct occurring when there is intentional failure to disclose or misrepresentation of relevant information while prosecuting a patent to deceive the USPTO.

In the past, it has been one of the most used defences in patent cases since any minor breach of disclosure may make the whole patent unenforceable. So pervasive was the use of the defence that it has been dubbed the atomic bomb of patent law due to the harsh consequences it brought about.

The legal stance took quite a turn after the Federal Circuit's ruling in the case of Therasense, Inc. v. Becton, Dickinson & Co. In this case, the court limited the application of the doctrine by establishing that the threshold of proving inequitable conduct should meet two separate elements, namely the intent to deceive the USPTO and materiality. This means that the proof of inequitable conduct must involve demonstrating the specific intent of the application to deceive the USPTO along with the fact that, without the materiality, the patent would not have been issued.

In other words, Therasense tried to achieve a compromise between deterring any form of willful misconduct and not accusing people of inequitable conduct because of innocent mistakes or negligence. However, the requirement of disclosure is still a cornerstone, and any kind of deliberate hiding of facts remains a punishable offence.

Patent Unenforceability

An instance of inequitable conduct will have repercussions which go beyond the patent claim. This is because, while most cases of invalidation of a patent concern particular claims, an instance of inequitable conduct can make the whole patent unenforceable. Even though the invention may be worth something economically or technologically, this does not matter since the patent cannot be enforced.

This will also have consequences for other related patents in the same patent family, especially when there is a similar pattern of prosecution in them. Therefore, this will not only have consequences for one application but also for the organisation's entire IP portfolio.

Patent Invalidity Challenges

Not disclosing the material prior art can further put the patent at risk of being invalidated. While going through an infringement suit, those accused of infringement often review the prosecution history to find out if there is any prior art that was not disclosed but could affect the outcome of the examination.

Even though omission of a reference in itself cannot be considered sufficient evidence for invalidation of a patent, undisclosed material information can make it easier for disputing parties to prove the invalidity of a patent.

Increased Litigation and Commercial Risks

Failure to disclose leads to potential litigation as well. Claims regarding inequitable conduct usually necessitate thorough investigation regarding the history of prosecution, interaction between inventors and their attorneys and the relevance of the undisclosed citations. This causes additional litigation expenses and delays even though inequitable conduct may not be proven in such cases.

The commercial consequences could prove equally important. Companies often utilize patents as a tool for attracting investments, establishing licensing agreements and pursuing mergers or acquisitions. In the course of due diligence, the prosecution history will come under scrutiny as far as its compliance with disclosure standards is concerned. Any queries about the adequacy of disclosures or the integrity of the prosecution process can undermine the patent's commercial prospects or value.

Remediating Disclosure Errors After Filing

Even though one finds out that there was an omission of material information in the application, it does not imply that the patent cannot be saved. Patent prosecution includes the submission of an Information Disclosure Statement even after the deadline has elapsed, provided that it follows all the pertinent rules.

Supplemental Examination is provided for those who have already obtained their patents. This method enables the patent holder to ask the USPTO to consider, reconsider or correct information which was not previously disclosed. It is not a defence for deliberate conduct; however, it serves as a significant remedy for mistakes in disclosure, thereby minimising any further problems regarding inequitable conduct.

Best Practices for Ensuring Compliance

The best method to prevent any dispute arising out of non-disclosure is through proactive compliance. The applicant should carry out a prior art search, maintain good communication between the inventors and the patent attorney, disclose new information and monitor the relevant foreign patent applications. This helps improve the entire patent prosecution process and the resultant patent.

Conclusion

The Information Disclosure Statement plays an essential role in the American patent system by guaranteeing that patent rights are issued only after thorough and proper examination. Even though Therasense may have increased the Standard required to prove inequitable conduct, one should not underestimate the importance of the responsibility of disclosing information. The best approach to getting a high-quality patent is making proper disclosure on time and using the right tools when necessary.

Author: Jewel James in case of any queries please contact/write back to us via email to content@khuranaandkhurana.com or at  Khurana & Khurana, Advocates and IP Attorney.

Endnotes

1. 37 C.F.R. § 1.56 (Duty to Disclose Information Material to Patentability), Code of Federal Regulations (United States Patent and Trademark Office).

2. 37 C.F.R. §§ 1.97–1.98 (Information Disclosure Statement—Content, Timing, and Requirements), Code of Federal Regulations (USPTO).

3. Therasense, Inc. v. Becton, Dickinson & Co., 649 F.3d 1276 (Fed. Cir. 2011) (en banc).

4. 35 U.S.C. § 257 (Supplemental Examination), Leahy-Smith America Invents Act, United States Code.

5. Manual of Patent Examining Procedure (MPEP) §§ 609, 2001–2004 (9th ed., Rev. 07.2022, Feb. 2023), United States Patent and Trademark Office.

6. United States Patent and Trademark Office (USPTO), Duty of Disclosure, Information Disclosure Statements, and Patent Examination Procedures, available through the Manual of Patent Examining Procedure (MPEP) and 37 C.F.R. §§ 1.56, 1.97–1.98.